Reduction of SARS-CoV-2 intra-household child-to-parent transmission associated with ventilation: results from a case-control study
- PMID: 37365557
- PMCID: PMC10294317
- DOI: 10.1186/s12889-023-16144-2
Reduction of SARS-CoV-2 intra-household child-to-parent transmission associated with ventilation: results from a case-control study
Abstract
Purpose: Our objective was to describe circumstances of SARS-CoV-2 household transmission and to identify factors associated with a lower risk of transmission in a nationwide case-control study in France.
Methods: In a descriptive analysis, we analysed cases reporting transmission from someone in the household (source case). Index cases could invite a non-infected household member to participate as a related control. In such situations, we compared the exposures of the index case and related control to the source case by conditional logistic regression matched for household, restricted to households in which the source case was a child, and the index case and related control were the infected child's parents.
Results: From October 27, 2020 to May 16, 2022, we included 104 373 cases for the descriptive analysis with a documented infection from another household member. The source case was mostly the index case's child (46.9%) or partner (45.7%). In total, 1026 index cases invited a related control to participate in the study. In the case-control analysis, we included 611 parental pairs of cases and controls exposed to the same infected child. COVID-19 vaccination with 3 + doses versus no vaccination (OR 0.1, 95%CI: 0.04-0.4), isolation from the source case (OR 0.6, 95%CI: 0.4-0.97) and the ventilation of indoor areas (OR 0.6, 95%CI: 0.4-0.9) were associated with lower risk of infection.
Conclusion: Household transmission was common during the SARS-CoV-2 pandemic in France. Mitigation strategies, including isolation and ventilation, decreased the risk of secondary transmission within the household.
Trial registration: ClinicalTrials.gov registration number: NCT04607941.
Keywords: Family; Home environment; Patient isolation; SARS-CoV-2; Ventilation.
© 2023. The Author(s).
Conflict of interest statement
FC receives consulting fees from Sanofi.
Figures


Similar articles
-
Risk of SARS-CoV-2 Infection Among Households With Children in France, 2020-2022.JAMA Netw Open. 2023 Sep 5;6(9):e2334084. doi: 10.1001/jamanetworkopen.2023.34084. JAMA Netw Open. 2023. PMID: 37713194 Free PMC article.
-
Source of SARS-CoV-2 infection: results from a series of 584,846 cases in France from October 2020 to August 2022.BMC Public Health. 2024 Jan 30;24(1):325. doi: 10.1186/s12889-024-17772-y. BMC Public Health. 2024. PMID: 38287286 Free PMC article.
-
Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study.CMAJ Open. 2022 Apr 12;10(2):E357-E366. doi: 10.9778/cmajo.20220026. Print 2022 Apr-Jun. CMAJ Open. 2022. PMID: 35414597 Free PMC article.
-
Effect of Inactivated SARS-CoV-2 Vaccines and ChAdOx1 nCoV-19 Vaccination to Prevent COVID-19 in Thai Households (VacPrevent trial).Int J Infect Dis. 2022 Nov;124:190-198. doi: 10.1016/j.ijid.2022.09.032. Epub 2022 Sep 28. Int J Infect Dis. 2022. PMID: 36180032 Free PMC article.
-
Impact of Vaccination With the SCB-2019 Coronavirus Disease 2019 Vaccine on Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Household Contact Study in the Philippines.Clin Infect Dis. 2023 Apr 3;76(7):1180-1187. doi: 10.1093/cid/ciac914. Clin Infect Dis. 2023. PMID: 36433685 Free PMC article.
Cited by
-
Factors Associated With the Transmission of the Delta Severe Acute Respiratory Syndrome Coronavirus 2 Variant in Households: The Israeli COVID-19 Family Study (ICoFS).J Infect Dis. 2025 Apr 15;231(4):e734-e742. doi: 10.1093/infdis/jiaf001. J Infect Dis. 2025. PMID: 39921601 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous